FEATURED NEWS

• HDA Statement on the Enactment of Bipartisan Opioid Legislation

  October 24, 2018

  Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to the enactment of the SUPPORT for Patients and Communities Act.

• HDA Research Foundation Launches Scholarship Program

  October 11, 2018

  The HDA Research Foundation is seeking to support the next generation of supply chain leaders through a new scholarship program. Created in conjunction with HDA’s professional development program, Convene, the HDA Research Foundation Scholarship is available biannually to graduate-level students currently working within HDA-member distributor and manufacturer companies.

• HDA Announces Drew and Mauch to Lead Board of Directors

  October 2, 2018

  The Healthcare Distribution Alliance (HDA) announces today the election of Greg Drew, President of Value Drug Company, as Chairman of HDA’s Board of Directors. Robert Mauch, PhD, PharmD, EVP and Group President at AmerisourceBergen Corporation, was elected Vice Chairman. The new leadership was announced at the HDA Annual Board and Membership Meeting.

• AAOA Launches Pharmacy Toolkit to Increase Pharmacist-Patient Engagement Around Safe Use, Storage and Disposal of Opioids

  September 18, 2018

  Allied Against Opioid Abuse (AAOA), a national initiative to help prevent prescription opioid abuse and misuse through education, has created a pharmacy toolkit (http://bit.ly/2xiNmnj) to equip pharmacists with resources to engage and educate patients about the safe use, storage and disposal of pain medicines.

• HDA Statement on Senate Passage of Legislation to Address Opioid Abuse Epidemic

  September 17, 2018

  Healthcare Distribution Alliance (HDA) President and CEO John M. Gray released the following statement on the Senate passage of comprehensive opioid legislation, the SUPPORT for Patients and Communities Act (H.R. 6).